Patent details

Basic Information

Publication number:

93391

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP131523409

Legal Status:

Active

Application number:

93391

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/13/894 (001-002)

Marketing Authorization Type:

Marketing Authorization Date:

17/01/2014

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

22/12/2016

First Marketing Authorization date:

17/01/2014

Grant date:

17/03/2017

Activation date:

21/04/2024

Publication date:

17/03/2017

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

17/01/2029

SPC Extension Expiration:

17/01/2029

Rejection date:

Withdrawal date:

Owner

From:

22/12/2016

 

 

Name:

Gilead Pharmasset LLC

Address:

c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

22/12/2016

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

Name:

Clark Jeremy

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

SPC2

Bulletin edition number:

2017/02

Publication date:

22/06/2017

Description:

Section D : Granted supplementary protection certificates – I2 publication

2

Bulletin Heading:

SPC3

Bulletin edition number:

2025/04

Publication date:

04/03/2025

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

30/04/2026

Annual Fee Number:

23

Annual Fee Amount:

430 Euro

Expected Payer:

Last Annual Fee Payment Date:

16/04/2025

Last Annual Fee Paid Number:

22

Last Annual Fee Paid Amount:

420 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
17/03/2017	Certificate	1
17/03/2017	Publication	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56